8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)

May 8, 2019

 

 

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-31553   36-4459170

(State or Other Jurisdiction

of Incorporation)

  (Commission File No.)  

(IRS Employer

Identification No.)

20 South Wacker Drive

Chicago, Illinois 60606

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock, $0.01 par value   CME   NASDAQ Global Select Market

 

 

 


Item 5.07.

Submission of Matters to a Vote of Security Holders.

CME Group Inc. (the “Company”) held its 2019 Annual Meeting of Shareholders on May 8, 2019.

At the close of business on March 11, 2019, the record date of the Annual Meeting, the Company had 357,838,971 shares of Class A and Class B common stock issued and outstanding. The following shares were present at the Annual Meeting, either in person or by proxy:

 

Class(es) of Common Stock

   Aggregate Number of Shares      % of the Issued
and Outstanding
 

Class A and Class B

     314,903,605        88.0

Class B-1

     252        40.32

Class B-2

     277        34.07

Class B-3

     338        26.26

The results of the proposals are as follows:

 

  1.

The election of seventeen Equity Directors to serve until 2020 (elected by the Class A and Class B shareholders voting together as a single class):

 

Name

   Votes For      Against      Abstain  

Terrence A. Duffy

     265,842,260        15,538,176        1,756,283  

Timothy S. Bitsberger

     275,297,733        7,441,427        397,559  

Charles P. Carey

     274,446,896        8,355,960        333,863  

Dennis H. Chookaszian

     266,905,182        15,308,931        922,606  

Ana Dutra

     279,847,449        2,816,246        473,024  

Martin J. Gepsman

     264,982,437        17,802,824        351,458  

Larry G. Gerdes

     268,438,343        13,828,583        869,793  

Daniel R. Glickman

     264,521,937        18,310,412        304,370  

Daniel G. Kaye

     279,997,548        2,616,197        522,974  

Phyllis M. Lockett

     273,279,832        9,377,159        479,728  

Deborah J. Lucas

     280,960,718        1,707,380        468,621  

Alex J. Pollock

     258,703,205        24,012,508        421,006  

Terry L. Savage

     267,690,742        14,526,593        919,384  

William R. Shepard

     246,846,793        35,994,464        295,462  

Howard J. Siegel

     273,456,653        9,419,610        260,456  

Michael A. Spencer

     273,221,320        9,423,609        491,790  

Dennis A. Suskind

     273,548,447        9,232,897        355,375  

There were a total of 31,766,886 broker non-votes in this proposal.

 

  2.

The ratification of the appointment of Ernst & Young LLP as the Company’s independent public accounting firm for 2019 (ratified by the Class A and Class B shareholders voting together as a single class):

 

Votes For

  

Votes Against

  

Abstentions

309,976,317    4,634,008    293,280


  3.

The approval, by advisory vote, of the compensation of the Company’s named executive officers (approved by the Class A and Class B shareholders voting together as a single class):

 

Votes For

  

Votes Against

  

Abstentions

264,977,444    16,653,580    1,505,695

There were a total of 31,766,886 broker non-votes in this proposal.

 

  4.

The election of Class B Directors:

 

  a.

The election of three Class B-1 Directors to serve until 2020 from a slate of six nominees (the nominees in bold were elected by the Class B-1 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Steve A. Beitler

     81        0        0  

Bradley S. Glass

     67        0        0  

Gedon Hertshten

     129        0        0  

William W. Hobert

     117        0        0  

Patrick J. Mulchrone

     108        0        0  

Robert J. Tierney Jr.

     140        0        0  

 

  b.

The election of two Class B-2 Director to serve until 2020 from a slate of three nominees (the nominees in bold were elected by the Class B-2 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Yra G. Harris

     139        1        0  

Ronald A. Pankau

     161        1        0  

David J. Wescott

     189        1        0  

 

  c.

In the election of one Class B-3 Director, no quorum was achieved. Therefore, Elizabeth A. Cook, who ran unopposed for this position, is a “holdover” under Delaware law and the Company’s bylaws. She will continue to serve until her successor is duly elected at the 2020 Annual Meeting or her earlier resignation or removal.

 

  5.

The election of Class B Nominating Committees:

 

  a.

The election of five members of the Class B-1 Nominating Committee to serve until 2020 from a slate of ten nominees (the nominees in bold were elected by the Class B-1 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Thomas A. Bentley

     129        0        0  

Kevin G. Boyle

     99        0        0  

Steven F. French

     100        0        0  

Joseph H. Gressel

     112        0        0  

Mark S. Kobilca

     79        0        0  

Gary T. Lark

     73        0        0  

W. Winfred (Fred) Moore II

     86        0        0  

James V. Sauter

     53        0        0  

Michael J. Small

     47        0        0  

Michael G. Sundermeier

     40        0        0  


  b.

The election of five members of the Class B-2 Nominating Committee to serve until 2020 from a slate of eight nominees (the nominees in bold were elected by the Class B-2 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Frank Catizone

     114        0        0  

Richard J. Duran

     137        0        0  

Patrick J. Lahey

     107        0        0  

Patrick W. Maloney

     120        0        0  

Andrew J. Schwieters

     43        0        0  

Stuart A. Unger

     138        0        0  

Barry D. Ward

     134        0        0  

James J. Zellinger

     94        0        0  

 

  c.

In the election of five members of the Class B-3 Nominating Committee, no quorum was achieved. In the absence of a quorum, the following Class B-3 Nominating Committee members who served at the time of the Annual Meeting are also deemed to continue to serve until their successors are duly elected at the 2020 Annual Meeting.

John F. Connors

Joel P. Glickman

Kevin P. Heaney

Thomas G. Rossi

Richard S. Turim


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CME Group Inc.
    Registrant
Date: May 13, 2019     By:   /s/ Kathleen M. Cronin
    Name:   Kathleen M. Cronin
    Title:   Senior Managing Director, General Counsel and Corporate Secretary